Providence Health & Services Clinical Trials
Sponsors / Providence Health & Services
Providence Health & Services appears as lead sponsor on 36 trial records in ClinicalTrials.gov. Of these, 6 are recruiting, 2 are active without new recruitment, and 13 have completed. The registry records 7 terminated or withdrawn trials for Providence Health & Services. The most common reasons cited for termination include slow or insufficient recruitment, efficacy or futility findings. Planned participant enrollment across these trials sums to 30,748. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.
36
Total Trials
6
Recruiting
2
Other Active
13
Completed
7
Terminated / Withdrawn
30,748
Total Enrollment
Termination reasons: Recruitment57% · Other29% · Efficacy14%
Recent Terminations
- NCT04796584 Stopped Oct 2022Multiple Sclerosis"Enrollment paused for greater than 6 months, data would not be relevant as enrollment took longer than expected."
- Heart Transplantation"Lack of efficacy"
- Melanoma"PI Discretion"
- Heart Failure"Unable to enroll and study intended patient population."
- Esophagitis"Lack of participant recruitment."
- Mucositis"Lack of participant recruitment."
- Depression"Too few interns willing to consent to wear the actigraph watches."
Active Trials (2 total)
- NCT04520711
- NCT07108660
- Cancer of the Head and Neck PHASE1NCT04470024
- Advanced Solid Tumors PHASE1NCT06719362
- NCT06175000
- Breast Cancer PHASE1NCT04895761
- Sepsis NANCT05784740
- Major Depressive Disorder PHASE2NCT06626152